Discount Agreements for Bevacizumab and Rituximab
Status
Active
Submission Deadline
614 days remaining
Contracting authority
GWQ ServicePlus AG50 more open tenders view
Location
Düsseldorf, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-362066-2026
Source
GWQ ServicePlus AG is seeking partners for non-exclusive discount agreements for the active ingredients Bevacizumab and Rituximab, starting 07/01/2026. All interested companies can join under the same conditions.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Restricted — LOT-0001RESTRICTED-DOCUMENT
- TED HTML — 362066-2026HTML
- TED PDF — 362066-2026PDF
- TED XML — 362066-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Lots (2)
- LOT-0001Rabattvereinbarung für Bevacizumab
- LOT-0002Rabattvereinbarung für Rituximab
Additional details
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Not allowed
Legal Basis
32014L0024